Author of the publication

Structural binding site comparisons reveal Crizotinib as a novel LRRK2 inhibitor

, , , , , and . Comput. Struct. Biotechnol. J., (June 2021)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

No persons found for author name Bolz, Sarah Naomi
add a person with the name Bolz, Sarah Naomi
 

Other publications of authors with the same name